PRSS53 is a potential novel biomarker related to prognosis and immunity in clear cell renal cell carcinoma
Authors
- Guocheng Liu (ORCID: https://orcid.org/0000-0001-8897-2338)
- Jiajun Zhang (ORCID: https://orcid.org/0000-0001-7107-4814)
- Wei Wang (ORCID: https://orcid.org/0000-0001-6853-7785)
Institutions
- Xuzhou Medical College (CN)
- Nantong University (CN)
- Yancheng First People's Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1007/s12672-025-02114-0
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Jiangsu Commission of Health